High-quality and representative clinical trial data has never been more critical for sponsors and contract research organizations (CROs), as they advance new treatments.
At Peters Medical Research (PMR), diversity and scientific precision go hand in hand—powering high-integrity results across Phase II–IV clinical studies.
With more than two decades of success completing nearly 300 clinical trials, it has earned a reputation for being not only a top enroller but also a full-spectrum top performer. As an affiliate of Bethany Medical, the largest independent healthcare provider in the Triad region, PMR taps directly into a database of more than 250,000 patients across 16 locations and 14 medical specialties. This network affords broad access to a diverse population that reflects the real-world diversity of our local communities. The site employs innovative recruitment strategies, strong community engagement and a commitment to underserved populations to ensure inclusivity.
“We partner with patients today to deliver the treatments of tomorrow, driving medical research forward with purpose, precision and speed,” says Dr. Lenin Peters, founder and CEO.
Dr. Peters, a gastroenterologist with hands-on experience in initial proton pump inhibitor studies, recognized early on that clinical trials often lacked diversity, limiting the applicability of their results. This insight became the catalyst for establishing PMR. Since PMR began over 20 year ago with a focus on GI disorders as their primary therapeutic area, the organization has since expanded to support clinical trials across myriad therapeutic areas.
PMR’s reputation for rapid, reliable enrollment is backed by measurable success. In a recent lung cancer study, the site enrolled 729 participants in just 12 months. A complex migraine trial reached its target of nearly two dozen participants in only one month, and an obesity study achieved full randomization in under six weeks—clear evidence of PMR’s operational excellence and recruitment expertise.
Committed to broadening access to clinical research, PMR continuously refines its recruitment strategies to reach underserved and low-income communities. Recognizing that trial participation can feel intimidating for those unfamiliar with medical research, the organization places strong emphasis on health literacy and community education. Through Bethany Medical Clinic, PMR provides accessible educational materials and resources that empower patients to make informed decisions about participation. By integrating marketing, branding, and innovative educational approaches, PMR builds awareness, fosters trust, and ensures that research opportunities are inclusive and approachable for all.
A recent gastrointestinal study highlights PMR’s community-centered approach in action. When early enrollment fell short of expectations, the team broadened its outreach efforts and placed greater emphasis on patient education. By taking time to build trust with participants new to clinical research, PMR not only improved enrollment rates but also inspired word-of-mouth referrals that extended participation across families and communities.
-
At PMR, we partner with patients today to deliver the treatments of tomorrow, driving medical research forward with purpose, precision, and speed.
A recent gastrointestinal study highlights PMR’s community-centered approach in action. When early enrollment fell short of expectations, the team broadened its outreach efforts and placed greater emphasis on patient education. By taking time to build trust with participants new to clinical research, PMR not only improved enrollment rates but also inspired word-of-mouth referrals that extended participation across families and communities.
CROs and biopharma partners turn to PMR not only for its strong enrollment performance but for an infrastructure built to handle the complexity of modern clinical trials. The site offers comprehensive in-house capabilities—including imaging, accredited sleep and endoscopy labs, and full diagnostic services—supported by regulatory expertise and IRB submission management. A centralized governance model and deep operational experience enable rapid study startup and seamless execution from patient visit to database lock. Unlike larger institutions, PMR delivers the agility, flexibility, and responsiveness needed to keep patients engaged in cutting-edge therapies. Its patient-first model extends beyond the clinic, offering evening and weekend appointments as well as transportation support to make participation accessible and sustainable, particularly for working individuals.
Looking ahead, PMR is redefining what’s possible in clinical research. The team is investing in the next generation of innovation—from AI-driven recruitment and decentralized trial models to more personalized, technology-enabled patient engagement. For sponsors and CROs, PMR represents more than a high-performing site; it’s a partner committed to speed, diversity, and data integrity.
By uniting cutting-edge science with human-centered care, PMR helps bring breakthrough therapies to patients faster—and with greater equity than ever before.
Peters Medical Research: Advancing Clinical Trials with Expertise and Care
Roy J Peters, MD, CPI, Chief Medical Officer
At Peters Medical Research, we believe high-quality data and compassionate care go hand in hand. When participants feel informed, respected, and supported, research moves forward with integrity—and that ultimately benefits everyone.
Deep Dive
Selecting Clinical Trial Services For Reliable Study Execution
Clinical trial procurement often turns on a gap between protocol ambition and what a research site can actually deliver. A sponsor may have a sound study design yet lose time when enrollment assumptions prove optimistic or qualified participants are difficult to identify. Site limitations can then compound the problem once recruitment begins. Every week lost at the site level can ripple into broader sponsor timelines. For buyers, the central question is not whether a provider can open a study. It is whether the provider can translate protocol requirements into dependable participant flow without adding avoidable delay.
Recruitment deserves close scrutiny because the headline database size can be misleading. A large contact pool has limited value if records are poorly matched to inclusion criteria or outreach cannot produce responsive candidates. Buyers need evidence that a provider understands the populations available to it and can screen against study requirements early. Recruitment also has to remain productive when eligibility rules narrow the field. Geographic reach matters when it extends access beyond patients who typically enter research through major academic centers, especially for protocols that depend on broader representation.
Execution capacity becomes a different pressure point once candidates begin entering the study. Complex protocols can demand repeated visits and specialized procedures, while investigators and research staff still have to keep scheduling disciplined. A provider needs enough physical capacity to handle study activity without creating bottlenecks, and its clinical personnel must be able to manage protocol requirements consistently. Narrow enrollment windows leave little tolerance for handoffs that slow appointments or leave sponsor teams waiting for answers. Buyers should probe how staffing depth and facility capacity hold up when several study demands converge.
Protocol fit should also be examined against the intended trial phase and patient population. Phase 2 through phase 4 studies place different demands on participant flow and visit management. A provider that already works across those phases can reduce the amount of adjustment required when a new protocol arrives. Diversity within the available participant base can be equally important when a study needs access to populations that are difficult to reach through traditional research centers. The useful question is whether the site’s real patient access matches the protocol on paper. Screening history can reveal whether apparent patient volume holds up once protocol exclusions are applied.
“Peters Medical Research’s reach across the Piedmont Triad gives sponsors access to a broad patient pool outside a major academic center.”
Speed, then, should be treated as an output rather than a promise. Fast enrollment is useful only when candidate identification remains disciplined, and study conduct keeps pace with recruitment. A credible clinical trial services partner should give buyers confidence in the front end of participant identification and in the work required after enrollment. Sponsor timelines become less dependent on feasibility assumptions that cannot be supported at the site level.
Peters Medical Research warrants close consideration where recruitment depth and site capacity dominate the buying decision. It supports phase 2 through phase 4 studies from a 21,000-square-foot research facility in High Point, North Carolina and draws on a database of more than 250,000 potential participants. Its reach across the Piedmont Triad gives sponsors access to a broad patient pool outside a major academic center. Peters Medical Research combines that recruitment base with physician-led study oversight and dedicated clinical research staff supporting study coordination. Enrollment-sensitive protocols leave little room for site-level delay and depend on real patient access.
...Read more
Clinical Trial Service Info
Q1
What distinguishes Peters Medical Research among Top Clinical Trial Services providers?
Peters Medical Research has earned recognition among Top Clinical Trial Services providers through its physician-led research model and its strong focus on patient-centered clinical studies. The company conducts Phase II through Phase IV trials across multiple therapeutic areas while maintaining close collaboration between investigators, sponsors and study participants. Its integrated clinical research infrastructure supports efficient patient recruitment, protocol execution and regulatory compliance within community-based healthcare settings. Peters Medical Research also differentiates itself through its emphasis on personalized participant engagement and high-quality data collection designed to support reliable study outcomes. (lifesciencesreview.com )
Q2
How does Peters Medical Research approach clinical study management?
Efficient coordination and investigator involvement shape the company’s operational strategy. Unlike some Clinical Trial Services providers that rely heavily on decentralized oversight, Peters Medical Research maintains direct physician participation throughout study execution to support consistency and patient safety. Its research teams manage protocol implementation, participant monitoring, informed consent procedures and regulatory documentation with close attention to trial accuracy and compliance standards. The company also emphasizes responsive communication with sponsors and research partners to help maintain study timelines and operational transparency. (lifesciencesreview.com )
Q3
Why is Peters Medical Research relevant to today’s clinical research environment?
Clinical research organizations increasingly need reliable study sites capable of balancing patient engagement with accurate protocol execution. Peters Medical Research addresses these demands through Clinical Trial Services designed to support efficient enrollment, strong retention rates and high-quality clinical data collection. Its community-based research model helps improve participant accessibility while maintaining professional clinical oversight throughout the study process. The company’s ability to conduct trials across multiple therapeutic categories also strengthens its relevance within an evolving clinical research environment focused on broader patient participation and real-world healthcare integration. (lifesciencesreview.com )
Q4
What role does medical expertise play in Peters Medical Research’s operations?
Clinical oversight remains central to the company’s research capabilities. Peters Medical Research combines experienced investigators, trained study coordinators and regulatory personnel to support accurate study execution and patient safety management. Its physician-led structure allows medical expertise to remain closely integrated with recruitment, participant assessment and treatment monitoring throughout each trial. Clinical Trial Services providers often differentiate themselves through operational consistency and investigator engagement, and Peters Medical Research reinforces that distinction through hands-on clinical involvement and attention to protocol integrity. (lifesciencesreview.com )
Q5
How does Peters Medical Research support study participants and sponsors?
Participant care and sponsor collaboration play important roles in the company’s service philosophy. Peters Medical Research works closely with study participants to support education, scheduling coordination and ongoing communication throughout trial participation. Its teams also provide sponsors with responsive reporting, protocol adherence monitoring and operational updates designed to improve study visibility and execution efficiency. Among Clinical Trial Services providers, the company stands out for maintaining a patient-focused environment while supporting sponsor expectations around data quality and regulatory compliance. (lifesciencesreview.com )
Q6
Why has Peters Medical Research gained recognition in clinical research?
Industry recognition for Peters Medical Research reflects its commitment to patient-centered research, physician-led oversight and dependable study execution. The company continues to strengthen its reputation through consistent support for sponsors conducting clinical development programs across multiple healthcare sectors. Its focus on participant engagement, operational responsiveness and regulatory accuracy contributes to efficient trial management and reliable clinical outcomes. This combination of medical expertise, patient support and research coordination reinforces Peters Medical Research’s standing within Clinical Trial Services. (lifesciencesreview.com )
